SCHEMBL4430416

SCHEMBL4430416

CNC(=O)[C@@H](NCC[C@H](c1ccc(OC)cc1)c1cccnc1OC)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48
BLM P54132 1/20 0.46
KMT2A Q03164 7/20 0.46
CASR P41180 2/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
MITF O75030 1/20 0.45
MEN1 O00255 5/20 0.44
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
GPR88 Q9GZN0 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432975 1.00 CNR1 (0.48) CNR1CNR2BLMKMT2ACASR
SCHEMBL4436222 0.89 KDM4E (0.40) CNR1CNR2KMT2ALMNAHTT
SCHEMBL4435280 0.89 KDM4E (0.40) CNR1CNR2KMT2ALMNAHTT
SCHEMBL4441873 0.82 KMT2A (0.67) CNR1CNR2BLMKMT2ACASR
SCHEMBL4428018 0.81 CNR1 (0.57) CNR1CNR2BLMKMT2ACASR
SCHEMBL4440475 0.81 CNR1 (0.57) CNR1CNR2BLMKMT2ACASR
SCHEMBL4434954 0.81 CNR1 (0.54) CNR1CNR2BLMKMT2ACASR
SCHEMBL4435363 0.81 CNR1 (0.54) CNR1CNR2BLMKMT2ACASR
SCHEMBL3736005 0.79 BLM (0.45) BLMKMT2ALMNAALDH1A1MAPT
SCHEMBL3737907 0.79 BLM (0.45) BLMKMT2ALMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed